Home > Compound List > Product Information
VU0240551_Molecular_structure_CAS_893990-34-6)
Click picture or here to close

VU0240551

Catalog No. V3890 Name Sigma Aldrich
CAS Number 893990-34-6 Website http://www.sigmaaldrich.com
M. F. C16H14N4OS2 Telephone 1-800-521-8956
M. W. 342.43856 Fax
Purity ≥98% (HPLC) Email
Storage Chembase ID: 154386

SYNONYMS

IUPAC name
N-(4-methyl-1,3-thiazol-2-yl)-2-[(6-phenylpyridazin-3-yl)sulfanyl]acetamide
IUPAC Traditional name
N-(4-methyl-1,3-thiazol-2-yl)-2-[(6-phenylpyridazin-3-yl)sulfanyl]acetamide
Synonyms
N-(4-Methyl-2-thiazolyl)-2-[(6-phenyl-3-pyridazinyl)thio]-acetamide
SID 56405457
VU0240551-1
VU0240551-2-D4
CID 7211972

DATABASE IDS

CAS Number 893990-34-6
MDL Number MFCD05957363

PROPERTIES

Empirical Formula (Hill Notation) C16H14N4OS2
Purity ≥98% (HPLC)
Apperance powder
Solubility DMSO: >20 mg/mL
MSDS Link Download
Storage Temperature 2-8°C
German water hazard class 3

DETAILS

Description (English)
Biochem/physiol Actions
VU0240551 is a potent, selective KCC2 inhibitor. KCC2 is a potassium-chloride exchanger expressed specifically in neurons. KCC2 functions to lower intracellular chloride concentrations below the electrochemical potential of the cells, thereby increasing the hyperexcitability of the neurons. KCC2 activity enhances GABA and other inhibitory neurotransmission and is implicated in pain processing. VU0240551 was discovered in a high-throughput screen, followed by directed medicinal chemistry. VU0240551 is selective for KCC2 over NKCC1. VU0240551 binds competitively to the K+ site and binds noncompetitively to the Cl- site. VU0240551 is the only small molecule with specificity for a KCC family member.
Description (简体中文)
Biochem/physiol Actions
VU0240551 is a potent, selective KCC2 inhibitor. KCC2 is a potassium-chloride exchanger expressed specifically in neurons. KCC2 functions to lower intracellular chloride concentrations below the electrochemical potential of the cells, thereby increasing the hyperexcitability of the neurons. KCC2 activity enhances GABA and other inhibitory neurotransmission and is implicated in pain processing. VU0240551 was discovered in a high-throughput screen, followed by directed medicinal chemistry. VU0240551 is selective for KCC2 over NKCC1. VU0240551 binds competitively to the K+ site and binds noncompetitively to the Cl- site. VU0240551 is the only small molecule with specificity for a KCC family member.

REFERENCES